MediPharm Labs Corp.

CVE:LABS ISIN:CA58504D1006

MediPharm Labs (CVE:LABS), through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

     

News

MMJ Group Holdings Ltd (ASX:MMJ) MediPharm Labs (CVE:LABS) Enters Contract with Canopy Growth

🕔11/30/2018 12:23:45 PM 1446

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release announcing that MediPharm Labs Inc (CVE:LABS) has entered into an 18-month strategic supply agreement with Canopy Growth Corporation (TSE:WEED) (NYSE:CGC).

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs (CVE:LABS) Enters Contract with Supreme Cannabis

🕔11/15/2018 10:44:42 AM 1782

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) announcing that it has entered into a 3-year cannabis concentrate program agreement with Supreme Cannabis Company Inc (CVE:FIRE).

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs receives sales licence

🕔11/13/2018 9:27:38 AM 1438

MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming that it has been issued a sales licence by Health Canada.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs Production Milestone

🕔11/8/2018 10:26:43 AM 1615

MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to attach a copy of a news release by MediPharm Labs Inc (CVE:LABS) confirming achievement of the significant milestone of the purification and production of 150,000 grams of cannabis extract.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs (CVE:LABS) Management Presentation

🕔10/23/2018 11:07:17 AM 1549

MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a copy of the management presentation published by MediPharm Labs Inc (TSX-V: LABS).

Read Full Article
###

0 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 95) (Last 30 Days: 808) (Since Published: 1483) 

Markets CVE:LABS

Company Data

    Headquarters
  • 151 John Street
    Barrie, Ontario
    L4N 2L1
    Canada
  • Telephone
  • +1-705-719-7425  
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.medipharmlabs.com
  • E:
  • investors@medipharmlabs.com

Social Media